Security Snapshot

TENET HEALTHCARE CORP - Common Stock (THC) Institutional Ownership

CUSIP: 88033G407

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

685

Shares (Excl. Options)

81,970,604

Price

$188.71

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Type / Class
Equity / Common Stock
Symbol
THC on NYSE
Shares outstanding
87,110,513
Price per share
$191.68
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
81,970,604
Total reported value
$15,473,281,118
% of total 13F portfolios
0.01%
Share change
-2,359,904
Value change
-$473,683,547
Number of holders
685
Price from insider filings
$191.68
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Key facts

  • THC - TENET HEALTHCARE CORP - Common Stock is tracked under CUSIP 88033G407.
  • 685 institutions reported positions in Q1 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 702 to 685 between Q4 2025 and Q1 2026.
  • Reported value moved from $16,805,305,155 to $15,473,281,118.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 685 institutions filings for Q1 2026.

Open SEC Evidence

Security key

88033G407

Latest holder period

Q1 2026

13F holders

685

13D/G owners

3

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
THC
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 8.8% $1,024,603,493 8,391,511 BlackRock, Inc. 31 Mar 2025
VANGUARD CAPITAL MANAGEMENT LLC 5.3% $864,671,673 4,582,013 Vanguard Capital Management 31 Mar 2026
Invesco Ltd. 4.4% $509,469,088 4,172,556 Invesco Ltd. 31 Mar 2025

As of 31 Mar 2026, 685 institutional investors reported holding 81,970,604 shares of TENET HEALTHCARE CORP - Common Stock (THC). This represents 94% of the company’s total 87,110,513 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
69%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 10% 8,704,644 +2% 0.03% $1,642,653,293
FMR LLC 8.9% 7,776,579 +1.8% 0.08% $1,467,518,141
PRICE T ROWE ASSOCIATES INC /MD/ 8.6% 7,518,742 +0.38% 0.16% $1,418,863,000
VANGUARD PORTFOLIO MANAGEMENT LLC 5% 4,316,887 0% 0.04% $814,639,746
VANGUARD CAPITAL MANAGEMENT LLC 4.5% 3,911,408 0% 0.02% $738,121,804
Boston Partners 4.4% 3,834,961 +5.3% 0.76% $723,650,402
STATE STREET CORP 3.1% 2,715,925 +0.84% 0.02% $512,522,207
WELLINGTON MANAGEMENT GROUP LLP 2.7% 2,344,919 +106% 0.08% $442,509,664
LONE PINE CAPITAL LLC 2.6% 2,258,717 +26% 3.4% $426,242,485
GEODE CAPITAL MANAGEMENT, LLC 2.2% 1,930,447 +12% 0.02% $364,369,261
Invesco Ltd. 2.1% 1,787,016 -9.5% 0.05% $337,227,755
GLENVIEW CAPITAL MANAGEMENT, LLC 1.8% 1,524,854 -23% 7.8% $287,755,198
AMERIPRISE FINANCIAL INC 1.7% 1,492,120 -14% 0.07% $281,577,502
AQR CAPITAL MANAGEMENT LLC 1.7% 1,442,588 -36% 0.12% $272,230,699
DIMENSIONAL FUND ADVISORS LP 1.4% 1,200,882 -5.9% 0.05% $226,623,742
MORGAN STANLEY 0.91% 795,834 -5.3% 0.01% $150,181,902
EMINENCE CAPITAL, LP 0.91% 790,302 +29% 3.4% $149,137,890
NORTHERN TRUST CORP 0.9% 785,306 +1.9% 0.02% $148,195,095
BANK OF AMERICA CORP /DE/ 0.89% 771,825 -36% 0.01% $145,651,187
Allianz Asset Management GmbH 0.88% 768,168 -12% 0.17% $144,960,984
VICTORY CAPITAL MANAGEMENT INC 0.88% 768,058 +5% 0.09% $144,940,226
ALLIANCEBERNSTEIN L.P. 0.8% 699,157 -5.6% 0.05% $138,936,479
Pacer Advisors, Inc. 0.78% 678,542 +58% 0.34% $128,047,661
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 0.77% 671,700 +57% 0.07% $126,756,507
Qube Research & Technologies Ltd 0.75% 653,332 +324% 0.18% $123,290,282

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
49
Latest
Q1 2026
Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 81,970,604 $15,473,281,118 -$473,683,547 $188.71 685
2025 Q4 84,556,090 $16,805,305,155 +$194,480,900 $198.72 702
2025 Q3 83,524,934 $16,956,383,383 -$548,485,967 $203.04 673
2025 Q2 86,705,205 $15,256,042,920 -$242,114,800 $176.00 619
2025 Q1 88,102,608 $11,848,580,868 -$297,990,635 $134.50 557
2024 Q4 90,782,644 $11,460,937,238 +$74,973,470 $126.23 571
2024 Q3 88,853,987 $14,755,648,870 -$388,930,023 $166.20 596
2024 Q2 92,054,252 $12,246,548,506 -$231,494,763 $133.03 522
2024 Q1 93,979,649 $9,878,072,066 +$21,023,735 $105.11 448
2023 Q4 95,052,239 $7,183,420,124 -$61,999,835 $75.57 420
2023 Q3 96,023,570 $6,326,878,906 -$70,153,915 $65.89 405
2023 Q2 95,766,096 $7,793,537,068 -$238,287,442 $81.38 410
2023 Q1 99,389,967 $5,903,975,587 -$260,800,223 $59.42 359
2022 Q4 104,685,581 $5,107,056,484 -$189,448,183 $48.79 349
2022 Q3 107,996,779 $5,568,387,416 +$91,465,890 $51.58 346
2022 Q2 105,740,110 $5,559,583,262 -$63,755,091 $52.56 347
2022 Q1 105,282,868 $9,052,535,353 +$282,827,156 $85.96 388
2021 Q4 102,521,862 $8,374,229,051 +$119,235,986 $81.69 361
2021 Q3 100,968,332 $6,709,151,477 +$55,798,127 $66.44 326
2021 Q2 100,293,045 $6,718,584,522 +$246,651,010 $66.99 314
2021 Q1 97,408,920 $5,065,644,752 -$60,322,413 $52.00 299
2020 Q4 99,122,344 $3,958,107,321 -$64,323,227 $39.93 264
2020 Q3 102,234,584 $2,504,131,936 +$7,053,786 $24.51 234
2020 Q2 102,228,001 $1,850,912,849 +$1,244,953 $18.11 224
2020 Q1 104,884,711 $1,510,464,449 -$62,618,800 $14.40 240
2019 Q4 103,527,921 $3,934,674,864 -$213,112,670 $38.03 256
2019 Q3 109,824,690 $2,428,280,890 +$92,511,192 $22.12 235
2019 Q2 105,979,797 $2,185,403,553 +$35,545,953 $20.66 235
2019 Q1 103,605,019 $2,986,181,928 +$15,127,630 $28.84 251
2018 Q4 104,460,437 $1,789,770,177 -$126,837,659 $17.14 254
2018 Q3 108,937,826 $3,099,894,673 +$63,271,498 $28.46 250
2018 Q2 106,334,815 $3,569,754,759 -$165,762,173 $33.57 242
2018 Q1 112,004,501 $2,716,128,701 -$112,384,909 $24.25 227
2017 Q4 120,099,329 $1,820,709,170 -$113,671,487 $15.16 223
2017 Q3 127,841,674 $2,100,033,634 +$145,149,848 $16.43 233
2017 Q2 117,323,436 $2,268,906,016 +$91,431,122 $19.34 234
2017 Q1 113,160,326 $2,003,985,108 +$458,866,205 $17.71 241
2016 Q4 101,576,997 $1,507,446,454 +$4,383,004 $14.84 247
2016 Q3 99,036,234 $2,242,080,002 -$49,420,243 $22.66 253
2016 Q2 100,077,533 $2,766,065,984 -$40,378,140 $27.64 249
2016 Q1 101,442,845 $2,934,194,257 -$50,722,671 $28.93 261
2015 Q4 102,781,234 $3,113,900,998 -$26,532,051 $30.30 268
2015 Q3 101,393,770 $3,743,094,540 +$37,675,701 $36.92 303
2015 Q2 98,165,333 $5,680,747,480 +$36,900,177 $57.88 327
2015 Q1 98,167,318 $4,857,964,129 +$154,125,547 $49.51 303
2014 Q4 95,006,721 $4,811,470,511 -$57,730,542 $50.67 313
2014 Q3 95,528,364 $5,673,545,364 -$56,755,342 $59.39 306
2014 Q2 97,262,068 $4,565,394,023 +$16,257,278 $46.94 284
2014 Q1 98,620,050 $4,221,007,463 +$260,249,863 $42.81 282
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .